Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
申请人:Mitsubishi Yuka Pharmaceutical Co., Ltd.
公开号:EP0028031A1
公开(公告)日:1981-05-06
There are presented novel quinazoline derivatives, namely 2-(4-substituted-carbamoyl-piperazin-1-yl)quinazoline derivatives, 2-(4-substituted-carbamoyl-homopiperazin-1--yl)quinazoline derivatives, 2-(4-substituted-thiocarbamoyl--piperazin-a-yl)quinazoline derivatives and 2-(4-substituted--thiocarbamoyl-piperazin-1-yl)quinazoline derivatives and a process for producing same. In form of pharmaceutical preparation said derivatives exhibit excellent antihypertensive activities.
本文介绍了新型喹唑啉衍生物,即 2-(4-取代-氨基甲酰基-哌嗪-1-基)喹唑啉衍生物、2-(4-取代-氨基甲酰基-高哌嗪-1-基)喹唑啉衍生物、2-(4-取代-硫代氨基甲酰基-哌嗪-a-基)喹唑啉衍生物和 2-(4-取代-硫代氨基甲酰基-哌嗪-1-基)喹唑啉衍生物及其生产工艺。上述衍生物以药物制剂的形式表现出卓越的抗高血压活性。